Skip to main content
. 2024 Jan 22;70:103054. doi: 10.1016/j.redox.2024.103054

Fig. 1.

Fig. 1

Ldlr−/−mice transplanted with Acod1−/−bone marrow contain more circulating and splenic Ly6cLowpatrolling monocytes. A) Irradiated atherosclerosis-susceptible Ldlr−/− mice were transplanted with either Acod1+/+ or Acod1−/− bone marrow (BM) and were given 6 weeks for efficient engraftment prior to initiating a high-fat diet (HFD). Blood samples are taken on weeks 0, 5 and 8 of HFD and mice were sacrificed on week 9. B) leukocyte subsets in Acod1+/+Ldlr−/− (filled) or Acod1−/−Ldlr−/− (checkered) mice at week 8 expressed as a percentage of circulating CD45+ cells (n = 22/23 for Acod1+/+Ldlr−/−/Acod1−/−Ldlr−/−, unpaired t-test). C) Blood monocytes in Acod1+/+Ldlr−/− (filled) or Acod1−/−Ldlr−/− (checkered) mice at week 0, 5 and 8 expressed as a percentage of circulating CD45+ cells (n = 22/23 for Acod1+/+Ldlr−/−/Acod1−/−Ldlr−/−, two-way ANOVA). D) Blood Ly6C monocyte subsets in Acod1+/+Ldlr−/− (filled) or Acod1−/−Ldlr−/− (checkered) mice at week 8 expressed as a percentage of circulating CD45+ cells (n = 22/23, two-way ANOVA). E) Splenic monocytes in Acod1+/+Ldlr−/− (filled) or Acod1−/−Ldlr−/− (checkered) BM expressed as a percentage of splenic CD45+ cells (n = 17/18, unpaired t-test). F) Splenic Ly6C monocyte subsets in Acod1+/+Ldlr−/− (filled) or Acod1−/−Ldlr−/− (checkered) mice expressed as a percentage of splenic CD45+ cells (n = 17/18, two-way ANOVA). G) Ly6C low (left), intermediate (middle) and high (right) counts per mL of blood in Acod1+/+Ldlr−/− (filled) or Acod1−/−Ldlr−/− (checkered) mice at weeks 0, 5 and 8 of HFD (n = 22/23, two-way ANOVA). Gating strategies for flow cytometry is provided in Supplemental Fig. 3. Data points display individual mice and error bars show SD.